International Biotechnology Trust plc specializes in investments in development stage and late stage companies. The majority of the fund's assets are generally invested in smaller and mid-capitalization quoted companies, with a minority in larger capitalization quoted companies. It makes long only investments. It prefers to invest in quoted or unquoted biotechnology and life sciences companies focused on drug discovery and development and in related sectors such as microbiology, life sciences, pharmaceutical research and development, gene research and development, medical devices or healthcare services. The fund seeks to invest in companies engaged in development and/or commercialization of a product, device or enabling technology and also invests in the therapeutic sub-sector. The fund also prefers to invest in companies with strong growth potential from the development and/or commercialization of either a biotechnology drug candidate, medical device or other enabling technology for medical research. It may also invest in specialty pharmaceuticals and life science tools. These companies can range from small private companies with strong science and people that need development funding, to large, multi-billion dollar biotechnology and medical device companies which have portfolios of products, many of which are already used in hospitals, clinics and pharmacies around the world. It makes majority of its investments in smaller and mid-capitalization quoted companies and seeks to invest up to thirty percent of the Company's assets in unquoted companies, while allowing an exposure of up to forty percent in unquoted companies (at the time of investment and after allowing for valuation write-ups and further follow-on investments). The fund typically invests in the United States, but seeks the best investments worldwide and so may also invest in Western Europe, Australia, and Asia. It typically invests between $1 million and $4 million in its portfolio companies. It exits its unquoted investments through the sale of these companies to strategic buyers including major pharmaceutical companies or, in some cases, and through a flotation.
International Biotechnology Trust Dividend Announcement
• International Biotechnology Trust announced a semi annually dividend of £14.50 per ordinary share which will be made payable on 2024-08-23. Ex dividend date: 2024-07-25
• International Biotechnology Trust annual dividend for 2024 was £14.50
• International Biotechnology Trust annual dividend for 2023 was £28.10
• International Biotechnology Trust's trailing twelve-month (TTM) dividend yield is 4.09%
• International Biotechnology Trust's payout ratio for the trailing twelve months (TTM) is 48.26%
• International Biotechnology Trust's dividend growth over the last five years (2018-2023) was -7.28% year
International Biotechnology Trust Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2024-07-25 | £14.50 | semi annually | 2024-08-23 |
2023-12-21 | £13.90 | semi annually | 2024-01-26 |
2023-07-27 | £14.20 | semi annually | 2023-08-25 |
2022-12-29 | £14.00 | semi annually | 2023-01-27 |
2022-08-04 | £15.70 | semi annually | 2022-08-26 |
2021-12-30 | £15.70 | semi annually | 2022-01-28 |
2021-07-15 | £14.20 | semi annually | 2021-08-27 |
2020-12-24 | £14.20 | semi annually | 2021-01-29 |
2020-07-16 | £12.40 | semi annually | 2020-08-28 |
2019-12-19 | £12.40 | semi annually | 2020-01-31 |
2019-07-18 | £14.00 | semi annually | 2019-08-30 |
2018-12-20 | £14.00 | semi annually | 2019-01-31 |
2018-08-02 | £13.50 | semi annually | 2018-08-31 |
2018-01-04 | £13.50 | semi annually | 2018-01-31 |
2017-08-03 | £11.50 | semi annually | 2017-08-31 |
2017-01-05 | £11.50 | semi annually | 2017-01-31 |
1995-11-13 | £1.00 | semi annually | 1995-12-08 |
International Biotechnology Trust Dividend per year
International Biotechnology Trust Dividend growth
International Biotechnology Trust Dividend Yield
International Biotechnology Trust current trailing twelve-month (TTM) dividend yield is 4.09%. Interested in purchasing International Biotechnology Trust stock? Use our calculator to estimate your expected dividend yield:
International Biotechnology Trust Financial Ratios
International Biotechnology Trust Dividend FAQ
Other factors to consider when evaluating International Biotechnology Trust as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy International Biotechnology Trust stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: International Biotechnology Trust's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, International Biotechnology Trust publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, International Biotechnology Trust distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from International Biotechnology Trust are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: International Biotechnology Trust sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, International Biotechnology Trust distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: International Biotechnology Trust declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of International Biotechnology Trust's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review International Biotechnology Trust's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.